Microport Scientific (MCRPF) 0.5700 $MCRPF
Intracranial Stents - 2015-2020 Global Strategic Business Report: Medical Tourism Buoys Demand for Stenting Procedures in Emerging Nations
M2 - Tue Mar 31, 6:17AM CDT
Research and Markets (http://www.researchandmarkets.com/research/24lv7t/intracranial) has announced the addition of the "Intracranial Stents - Global Strategic Business Report" report to their offering. This report analyzes the worldwide markets for Intracranial Stents in US$ Thousands. The report provides separate comprehensive analytics for the US, Europe, and Rest of World. Annual estimates and forecasts are provided for the period 2013 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 14 companies including many key and niche players such as: - Admedes Schuessler GmbH (Germany) - BALT Extrusion (France) - Cardiatis SA (Belgium) - Codman & Shurtleff, Inc. (US) - Covidien PLC (Ireland) - ITGI Medical Ltd. (Israel) - MicroPort Scientific Corporation (China) - OBEX Medical (New Zealand) - Stryker Corp. (US) Key Topics Covered: 1. INDUSTRY OVERVIEW 2. INTRACRANIAL STENTS AVAILABLE IN THE MARKET 3. MARKET DRIVERS & TRENDS 4. PRODUCT OVERVIEW 5. NEUROVASCULAR DISEASES - AN OVERVIEW 6. MAJOR NEUROVASCULAR INDICATIONS REQUIRING STENTING PROCEDURES 7. PRODUCT INTRODUCTIONS & APPROVALS 8. RECENT INDUSTRY ACTIVITY 9. FOCUS ON SELECT PLAYERS 10. GLOBAL MARKET PERSPECTIVE Total Companies Profiled: 14 (including Divisions/Subsidiaries - 17) - The United States (6) - Europe (6) - - France (1) - - Germany (3) - - Rest of Europe (2) - Asia-Pacific (Excluding Japan) (4) - Middle East (1) For more information visit http://www.researchandmarkets.com/research/24...tracranial
SYK: 93.74 (+0.67)
MediPoint: Coronary Stents - South America Analysis and Market Forecasts to 2020
M2 - Wed Mar 25, 6:07AM CDT
Research and Markets (http://www.researchandmarkets.com/research/lz276h/medipoint) has announced the addition of the "MediPoint: Coronary Stents - SA Analysis and Market Forecasts" report to their offering. The global coronary stents market is a dynamic, double-digit market that is saturated with numerous players developing innovative technologies. Rapid advances in the field of interventional cardiology along with the development of minimally invasive techniques have greatly expanded the potential of therapeutic applications. Coronary stents including bare metal, drug-eluting, covered and bioabsorbable stents can be used to treat coronary artery disease, and optimize outcomes. Minimally-invasive techniques such as stenting have been widely adopted in Brazil. The coronary stents market will be driven by the rising prevalence of CAD, the growing aging population, and the potential cost savings associated with DES technologies. Scope - An overview of Coronary Stents, which includes epidemiology, etiology, symptoms, diagnosis, pathology and treatment guidelines. - Annualized the SA Coronary Stents market revenue and future forecasts from 2011 to 2013, forecast for 7 years to 2020. - Investigation of current and future market competition for Coronary Stents. - Insightful review of the key industry drivers, restraints and challenges as well as predicted impact of key events. - Competitor assessment including device approval analysis and device sales forecasts. - Marketed and pipeline product profiles covering efficiency, safety, clinical study details, device approvals, product positioning and device sales forecast. - Analysis of unmet needs within the market and opportunities for future players. - Technology trends evaluation to assess strength of pipeline. - An overview of all devices in development including clinical study details, design and material selection considerations, efficacy reports, and device approval timelines. - Company profiles including business description, financial overview and SWOT analysis. - Coverage of key market players. - Strategic assessment of the Coronary Stents sector through market impact analysis, future market scenario and company analysis. - Direct quotes from Key Opinion Leaders (KOL) as well as doctors Key Topics Covered: 1 Tables & Figures 2 Introduction 3 Industry Overview 4 Unmet Needs 5 Market Opportunity Analysis 6 Market Drivers, Barriers, and Substitutes 7 Competitive Assessment 8 Pipeline Products 9 Clinical Trial Analysis 10 Current and Future Players 11 Market Outlook 12 Appendix Companies Mentioned - Abbott Vascular - Boston Scientific Corporation - Medtronic - Alvimedica - Amaranth Medical - amg International - Arterial Remodeling Technologies - B. Braun - Balton - Biosensors International - Biotronik - Blue Medical - Cardionovum - C.R. Bard - Elixir Medical Corporation - eucatech AG - Hexacath - JW Medical Systems - Kyoto Medical Planning - Lepu Medical Technology - MicroPort Scientific Corporation - Minvasys - MIV Therapeutics - Opto Circuits - OrbusNeich Medical - Relisys Medical Devices - Sahajanand Medical Technologies - Terumo Corporation - Translumina - Vascular Concepts For more information visit http://www.researchandmarkets.com/research/lz276h/medipoint
BSX: 18.10 (unch), MDT: 77.93 (+0.80)
MediPoint: Coronary Stents - APAC Analysis and Market Forecasts to 2020
M2 - Wed Mar 25, 5:47AM CDT
Research and Markets (http://www.researchandmarkets.com/research/qvwjmw/medipoint) has announced the addition of the "MediPoint: Coronary Stents - APAC Analysis and Market Forecasts" report to their offering. The APAC countries have diverse populations, ethnicities, and clinical practices. Many of the developed economies in these regions have a growing aging population, given the improvements made in healthcare (Cheng, 2010). Japan is one of the largest markets for cardiovascular devices in the world due to its advanced healthcare system and high pricing. In 2013, Among the emerging markets, which include Brazil, China, and India, China has the largest share in the coronary stents market for treating CAD. Scope - An overview of Coronary Stents, which includes epidemiology, etiology, symptoms, diagnosis, pathology and treatment guidelines. - Annualized the APAC Coronary Stents market revenue and future forecasts from 2011 to 2013, forecast for 7 years to 2020. - Investigation of current and future market competition for Coronary Stents. - Insightful review of the key industry drivers, restraints and challenges as well as predicted impact of key events. - Competitor assessment including device approval analysis and device sales forecasts. - Marketed and pipeline product profiles covering efficiency, safety, clinical study details, device approvals, product positioning and device sales forecast. - Analysis of unmet needs within the market and opportunities for future players. - Technology trends evaluation to assess strength of pipeline. - An overview of all devices in development including clinical study details, design and material selection considerations, efficacy reports, and device approval timelines. - Company profiles including business description, financial overview and SWOT analysis. - Coverage of key market players. - Strategic assessment of the Coronary Stents sector through market impact analysis, future market scenario and company analysis. - Direct quotes from Key Opinion Leaders (KOL) as well as doctors Key Topics Covered: 1 Tables & Figures 2 Introduction 3 Industry Overview 4 Unmet Needs 5 Market Opportunity Analysis 6 Market Drivers, Barriers, and Substitutes 7 Competitive Assessment 8 Pipeline Products 9 Clinical Trial Analysis 10 Current and Future Players 11 Market Outlook 12 Appendix Companies Mentioned - Abbott Vascular - Boston Scientific Corporation - Medtronic - Alvimedica - Amaranth Medical - amg International - Arterial Remodeling Technologies - B. Braun - Balton - Biosensors International - Biotronik - Blue Medical - Cardionovum - C.R. Bard - Elixir Medical Corporation - eucatech AG - Hexacath - IRAMED - JW Medical Systems - Kyoto Medical Planning - Lepu Medical Technology - MicroPort Scientific Corporation - Minvasys - MIV Therapeutics - Opto Circuits - OrbusNeich Medical - Relisys Medical Devices - REVA Medical - Sahajanand Medical Technologies - STENTYS For more information visit http://www.researchandmarkets.com/research/qvwjmw/medipoint
BSX: 18.10 (unch), MDT: 77.93 (+0.80)
Global Coronary Stents Market Outlook Report 2015 - Analysis and Forecasts 2007-2020
M2 - Thu Mar 19, 6:39AM CDT
Research and Markets (http://www.researchandmarkets.com/research/jfw4v9/global_coronary) has announced the addition of the "Global Coronary Stents Market Outlook, 2007 - 2020" report to their offering. The global coronary stent market is expected grow, despite the current downward trend in the US, the largest market, and declining selling prices globally. The market study takes into account various global clinical studies and pipeline products and it suggests that the coronary stent pipeline is clustered with new generation Drug Eluting Stent (DES), bioactive stents, bioabsorbable technology and stents for the niche segments such as complex and bifurcated vessels. Altering the trend, small to medium size companies from the developing economies are ambitiously conducting clinical studies to win the approvals and expand the use of devices for new indications. The stent market globally and in the developed nations is largely controlled by three playersAbbott Laboratories, Boston Scientific, and Medtronic. While in developing economies, small and medium players from Asia and Europe have a considerable share in terms of volume. This comprehensive, 465 page global strategic business report is authored by team of sector analysts who used rigorous primary and secondary research, robust analytical model to provide strategic insight and to forecast in for all major stent types BMS, DES, Bioabsorbable stents in leading 23 geographies. Key Topics Covered: 1. Charts & Tables 2. Executive Summary 3. Market at a Glance 4. Introduction to Stents 5. Coronary Stents 6. Types of Stents 7. Approvals 8. Competitive Landscape 9. Clinical Studies 10. Coronary Stents - Market Drivers and Restrains 11. Overview: Market trends 12. Approvals Driving the Growth 13. Market Data 14. Company Profiles 15. Recent Events 16. Appendix Companies Mentioned - Abbott Vascular - Alvimedica Medical Technologies - Arterial Remodeling Technologies - Boston Scientific Corporation - Biosensors International - Biotronik SE & Co.kG - CID S.r.l. - Clearstream Technologies Ltd. - Disa Vascular (Pty) Ltd. - Elixir Medical Corporation - Endocor Gmbh - Essen Technology (Beijing) Co., Ltd - Hexacath - Iberhospitex S.A - InspireMD, Inc. - Japan Stent Technology Co., Ltd. - Kyoto Medical - Lepu Medical Technology Co., Ltd. - Medinol - Medtronic, Inc. - Meril Life Sciences Pvt. Ltd. - Micell Technologies, Inc. - MicroPort Scientific Corporation - Minvasys - OrbusNeich - Relisys Medical Devices Limited - Reva Medical, Inc. - Sahajanand Medical Technologies - Stentys - Vascular Concepts For more information visit http://www.researchandmarkets.com/research/jf...l_coronary
BSX: 18.10 (unch), MDT: 77.93 (+0.80), NSPR: 0.32 (unch)
MediPoint: Coronary Stents - US Analysis and Market Forecasts
M2 - Thu Dec 04, 5:22AM CST
Research and Markets (http://www.researchandmarkets.com/research/xrr3sw/medipoint) has announced the addition of the "MediPoint: Coronary Stents - US Analysis and Market Forecasts" report to their offering. The global coronary stents market is a dynamic, double-digit market that is saturated with numerous players developing innovative technologies. Rapid advances in the field of interventional cardiology along with the development of minimally invasive techniques have greatly expanded the potential of therapeutic applications. Coronary stents including bare metal, drug-eluting, covered and bioabsorbable stents can be used to treat coronary artery disease, and optimize outcomes. Each year, millions of individuals are affected by CAD worldwide. Given the high burden of the disease, it is important to develop innovative technologies that can improve outcomes and disease management. Stenting for coronary applications has been widely adopted in clinical practice worldwide, and can be used in a wide range of indications. By 2020, the coronary stents market for BMS and DES is estimated to be over $5.61 billion. Key Topics Covered: 1 List of Tables 2 Introduction 3 Industry Overview 4 Unmet Needs 5 Market Opportunity Analysis 6 Market Drivers, Barriers, and Substitutes 7 Competitive Assessment 8 Pipeline Products 9 Clinical Trial Analysis 10 Current and Future Players 11 Market Outlook 12 Appendix Companies Mentioned: - Abbott Vascular - Alvimedica - Amaranth Medical - Arterial Remodeling Technologies - B. Braun - Balton - Biosensors International - Biotronik - Blue Medical - Boston Scientific Corporation - C.R. Bard - Cardionovum - Elixir Medical Corporation - Hexacath - IRAMED - JW Medical Systems - Kyoto Medical Planning - Lepu Medical Technology - MIV Therapeutics - Medtronic - MicroPort Scientific Corporation - Minvasys - Opto Circuits - OrbusNeich Medical - REVA Medical - Relisys Medical Devices - STENTYS - Sahajanand Medical Technologies - Terumo Corporation - Translumina - Vascular Concepts - amg International - eucatech AG For more information visit http://www.researchandmarkets.com/research/xrr3sw/medipoint
BSX: 18.10 (unch), MDT: 77.93 (+0.80)
MediPoint: Coronary Stents - Current and Future Players
M2 - Thu Dec 04, 4:11AM CST
Research and Markets (http://www.researchandmarkets.com/research/vrst8n/medipoint) has announced the addition of the "MediPoint: Coronary Stents - Current and Future Players" report to their offering. The global coronary stents market is a dynamic, double-digit market that is saturated with numerous players developing innovative technologies. Rapid advances in the field of interventional cardiology along with the development of minimally invasive techniques have greatly expanded the potential of therapeutic applications. Coronary stents including bare metal, drug-eluting, covered and bioabsorbable stents can be used to treat coronary artery disease, and optimize outcomes. The coronary stents market is a vast and dynamic market that is saturated with numerous players worldwide. The competitive landscape consists of large, mid-size, and small companies that have developed different types of coronary stents to target various coronary indications, such as de novo lesions, AMI, STEMI, SVD, and bifurcation lesions. The coronary stents market is largely dominated by a few key players, including Abbott Vascular, Boston Scientific, and Medtronic, followed by Biosensors International and Terumo Corporation. Scope - Investigation of current and future market competition for Coronary Stents. - Competitor assessment including device approval analysis. - Coverage of key market players and company profiles including business description, financial overview and SWOT analysis. - Strategic assessment of the device sector through market impact analysis, future market scenario and company analysis. - Direct quotes from Key Opinion Leaders (KOL) as well as doctors using Coronary Stents in clinical practice. Key Topics Covered: 1 List of Tables 2 Introduction 3 Competitive Assessment 4 Pipeline Products 5 Current and Future Players 6 Appendix Companies Mentioned: - Abbott Vascular - Alvimedica - Amaranth Medical - Arterial Remodeling Technologies - B. Braun - Balton - Biosensors International - Biotronik - Blue Medical - Boston Scientific Corporation - C.R. Bard - Cardionovum - Elixir Medical Corporation - Hexacath - IRAMED - JW Medical Systems - Kyoto Medical Planning - Lepu Medical Technology - MIV Therapeutics - Medtronic - MicroPort Scientific Corporation - Minvasys - Opto Circuits - REVA Medical - Relisys Medical Devices - STENTYS - Sahajanand Medical Technologies - Terumo Corporation - Translumina - Vascular Concepts - amg International - eucatech AG For more information visit http://www.researchandmarkets.com/research/vrst8n/medipoint
BSX: 18.10 (unch), MDT: 77.93 (+0.80)
MediPoint: Aortic Stent Grafts - South America Analysis and Market Forecasts
M2 - Thu Dec 04, 4:01AM CST
Research and Markets (http://www.researchandmarkets.com/research/8b8djj/medipoint_aortic) has announced the addition of the "MediPoint: Aortic Stent Grafts - South America Analysis and Market Forecasts" report to their offering. Aortic stent grafts are most commonly used to reinforce a weak spot in an artery, which is known as an aneurysm. The stent grafts are designed to seal tightly with the patient's native artery above and below the aneurysm, and are used to treat abdominal aortic aneurysms as well as thoracic aortic aneurysms. Reasons to buy - Understand the trends shaping and driving the South America Aortic Stent Grafts market. - Realize device preferences of physicians who have performed the tests already. - Access market sizing, forecasts and quantified growth opportunities in South America Aortic Stent Grafts market through 2018. - Quantify candidate patient populations to better design product pricing & launch plans. - Drive revenues, formulate effective sales and marketing strategies and gain in-depth understanding of the competitive landscape. - Perform benchmarking analysis of growth opportunities against currently marketed products. - Assess competitiveness of products in market by understanding the strengths and weaknesses of current competition. - Take a comprehensive look at the market's device pipeline and identify promising, paradigm-shifting products. - Create an effective counter-strategy to gain a competitive advantage against those currently in the market. Key Topics Covered: 1 List of Tables 2 Introduction 3 Industry Overview 4 Unmet Needs 5 Market Opportunity Analysis 6 Market Drivers, Barriers, and Substitutes 7 Competitive Assessment 8 Pipeline Assessment 9 Clinical Trials to Watch 10 Current and Future Players 11 Market Outlook 12 Appendix Companies Mentioned: - Altura Medical - Aptus Endosystems - B. Braun - Bolton Medical - Braile Biomedica - Cardiatis - Cook Medical - Endologix - Getinge Group - Gore Medical - Grikin Advanced Materials - Johnson & Johnson's Cordis Corporation - Jotec - LeMaitre Vascular - Lifetech Scientific - Lombard Medical - Medtronic - MicroPort Scientific Corporation - Nano Endoluminal - Terumo Corporation - TriVascular - Weike Medical Apparatus and Instrument - YTH Biological Material Scitech For more information visit http://www.researchandmarkets.com/research/8b...int_aortic
JNJ: 102.06 (+0.73), MDT: 77.93 (+0.80), EVAR: 4.09 (+0.01), LMAT: 8.38 (+0.08)
MediPoint: Aortic Stent Grafts - APAC Analysis and Market Forecasts
M2 - Thu Dec 04, 3:55AM CST
Research and Markets (http://www.researchandmarkets.com/research/fxpfd4/medipoint_aortic) has announced the addition of the "MediPoint: Aortic Stent Grafts - APAC Analysis and Market Forecasts" report to their offering. Aortic stent grafts are most commonly used to reinforce a weak spot in an artery, which is known as an aneurysm. The stent grafts are designed to seal tightly with the patient's native artery above and below the aneurysm, and are used to treat abdominal aortic aneurysms as well as thoracic aortic aneurysms. Reasons to buy - Understand the trends shaping and driving the APAC Aortic Stent Grafts market. - Realize device preferences of physicians who have performed the tests already. - Access market sizing, forecasts and quantified growth opportunities in the APAC Aortic Stent Grafts market through 2018. - Quantify candidate patient populations to better design product pricing & launch plans. - Drive revenues, formulate effective sales and marketing strategies and gain in-depth understanding of the competitive landscape. - Perform benchmarking analysis of growth opportunities against currently marketed products. - Assess competitiveness of products in market by understanding the strengths and weaknesses of current competition. - Take a comprehensive look at the market's device pipeline and identify promising, paradigm-shifting products. - Create an effective counter-strategy to gain a competitive advantage against those currently in the market. - Organize your sales and marketing efforts by identifying the market categories and segments that present the best opportunities for growth. Key Topics Covered: 1 List of Tables 2 Introduction 3 Industry Overview 4 Unmet Needs 5 Market Opportunity Analysis 6 Market Drivers, Barriers, and Substitutes 7 Competitive Assessment 8 Pipeline Assessment 9 Clinical Trials to Watch 10 Current and Future Players 11 Market Outlook 12 Appendix Companies Mentioned: - Altura - Aptus - B. Braun - Bolton - Braile Biomedica - Cardiatis - Cook - Endologix - Getinge - Gore - Grikin Advanced Materials - Johnson & Johnson's - Jotec - LeMaitre Vascular - Lifetech - Lombard - Medtronic - MicroPort Scientific - Nano Endoluminal - Terumo - TriVascular - Weike Medical Apparatus and Instrument - YTH Biological Material For more information visit http://www.researchandmarkets.com/research/fx...int_aortic
JNJ: 102.06 (+0.73), MDT: 77.93 (+0.80), LMAT: 8.38 (+0.08)
MediPoint: Aortic Stent Grafts - US Analysis and Market Forecasts 2013-2020
M2 - Mon Nov 24, 8:35AM CST
Research and Markets (http://www.researchandmarkets.com/research/lvjkp8/medipoint_aortic) has announced the addition of the "MediPoint: Aortic Stent Grafts - US Analysis and Market Forecasts" report to their offering. Aortic stent grafts are most commonly used to reinforce a weak spot in an artery, which is known as an aneurysm. The stent grafts are designed to seal tightly with the patient's native artery above and below the aneurysm, and are used to treat abdominal aortic aneurysms as well as thoracic aortic aneurysms. Aortic aneurysms, as opposed to aneurysms found elsewhere in the body, are potentially very serious, as a burst aorta results in massive internal bleeding that can be fatal unless treated rapidly by an experienced emergency medical team. The US market is the largest market for aortic stent grafts, accounting for more than 40% of the global market. The US market is very similar to that of the global market with regard to the trends in market share. Gore Medical remains the leader in the US for both the EVAR and TEVAR markets. These three companies also offer market leading products for treating AAA and TAA, ensuring long-term, effective solutions to patients. Scope - An overview of Aortic Stent Grafts, which includes epidemiology, etiology, symptoms, diagnosis, pathology and treatment guidelines. - Annualized the US Aortic Stent Grafts market revenue and future forecasts from 2011 to 2013, forecast for 7 years to 2020. - Investigation of current and future market competition for Aortic Stent Grafts. - Insightful review of the key industry drivers, restraints and challenges as well as predicted impact of key events. - Competitor assessment including device approval analysis and device sales forecasts. - Marketed and pipeline product profiles covering efficiency, safety, clinical study details, device approvals, product positioning and device sales forecast. - Analysis of unmet needs within the market and opportunities for future players. - Technology trends evaluation to assess strength of pipeline. - An overview of all devices in development including clinical study details, design and material selection considerations, efficacy reports, and device approval timelines. - Company profiles including business description, financial overview and SWOT analysis. - Coverage of key market players. - Strategic assessment of the Aortic Stent Grafts sector through market impact analysis, future market scenario and company analysis. - Direct quotes from Key Opinion Leaders (KOL) as well as doctors Key Topics Covered: 1 Tables & Figures 2 Introduction 3 Industry Overview 4 Unmet Needs 5 Market Opportunity Analysis 6 Market Drivers, Barriers, and Substitutes 7 Competitive Assessment 8 Pipeline Assessment 9 Clinical Trials to Watch 10 Current and Future Players 11 Market Outlook 12 Appendix Companies Mentioned - Altura Medical - Aptus Endosystems - B. Braun - Bolton Medical - Braile Biom?dica - Cardiatis - Cook Medical - Endologix - Getinge Group - Gore Medical - Grikin Advanced Materials - Johnson & Johnson's Cordis Corporation - Jotec - LeMaitre Vascular - Lifetech Scientific - Lombard Medical - Medtronic - MicroPort Scientific Corporation - Nano Endoluminal - Terumo Corporation - TriVascular - Weike Medical Apparatus and Instrument - YTH Biological Material Scitech For more information visit http://www.researchandmarkets.com/research/lv...int_aortic
JNJ: 102.06 (+0.73), MDT: 77.93 (+0.80), EVAR: 4.09 (+0.01), LMAT: 8.38 (+0.08)
MediPoint: Coronary Stents - Global Analysis and Market Forecasts to 2020 for the $5.6 Billion Industry
M2 - Fri Nov 21, 9:31AM CST
Research and Markets (http://www.researchandmarkets.com/research/dx86qv/medipoint) has announced the addition of the "MediPoint: Coronary Stents - Global Analysis and Market Forecasts" report to their offering. Coronary Stent Sales by Region Coronary stents can be used for a wide range of indications in coronary artery disease (CAD), including de novo lesions, small-vessel disease (SVD), bifurcation lesions, and tortuous and narrow lesions. Coronary stents can improve the clinical outcomes for all of these indications as well as quality of life for patients suffering from this debilitating disease. In 2013, sales of DES and BMS in the 10MM were $4.89 billion. The authors estimates the 2014 sales of DES and BMS in the 10MM to be $4.99 billion. By 2020, sales of coronary stents, including bare metal and drug-eluting stents, will grow to $5.62 billion, at a Compound Annual Growth Rate (CAGR) of 2.0%. To date, BAS have not received regulatory approval and been launched in the US, Japanese, and Chinese markets, but are expected to enter these markets in the near future. Of the 10MM covered in the report, the US currently has and will continue to have the largest share in the coronary stents market. Together, the US, the 5EU countries, and Japan will account for 64% of the coronary stents market for BMS and DES in 2020. Collectively, the 5EU countries are forecast to have only 10% market share in the future. Among the emerging markets, China has captured significant market share, which is expected to increase in the future. The emerging markets, including Brazil, China, and India, are expected to demonstrate the greatest growth in the market over the forecast period and will serve as an outlet of expansion for stent manufacturers to increase their global presence. The key drivers for the coronary stents market during the forecast period are: - The rising prevalence of CAD in the major markets covered in this report - The need for effective therapies that reduce the risk of complications, such as restenosis (re-narrowing of the coronary artery), chronic inflammation, and thrombosis, and the need for target lesion revascularization (TLR) associated with bare metal and drug-eluting stenting - The cost savings for healthcare payers resulting from the reduced need for repeat revascularization procedures and prolonged dual antiplatelet therapy - Reducing the need for stent-in-stent procedures and improving the technical feasibility of future interventions - Innovations in stent technology with regard to the platform, material, and coating - The increase in patients' disposable income and government insurance coverage in the emerging markets, such as China and India - The approval and launch of BAS, such as the Absorb BVS, in the US, Japan, and China Key Topics Covered: 1 Tables & Figures 2 Introduction 3 Industry Overview 4 Unmet Needs 5 Market Opportunity Analysis 6 Market Drivers, Barriers, and Substitutes 7 Competitive Assessment 8 Pipeline Products 9 Clinical Trial Analysis 10 Current and Future Players 11 Market Outlook 12 Appendix Companies Mentioned - Abbott Vascular - Alvimedica - Amaranth Medical - Arterial Remodeling Technologies - B. Braun - Balton - Biosensors International - Biotronik - Blue Medical - Boston Scientific Corporation - C.R. Bard - Cardionovum - Elixir Medical Corporation - Hexacath - IRAMED - JW Medical Systems - Kyoto Medical Planning - Lepu Medical Technology - MIV Therapeutics - Medtronic - MicroPort Scientific Corporation - Minvasys - Opto Circuits - OrbusNeich Medical - REVA Medical - Relisys Medical Devices - STENTYS - Sahajanand Medical Technologies - Terumo Corporation - Translumina For more information visit http://www.researchandmarkets.com/research/dx86qv/medipoint
BSX: 18.10 (unch), MDT: 77.93 (+0.80)
MediPoint: Aortic Stent Grafts - Current and Future Players
M2 - Tue Nov 18, 8:37AM CST
Research and Markets (http://www.researchandmarkets.com/research/pk7mdq/medipoint_aortic) has announced the addition of the "MediPoint: Aortic Stent Grafts - Current and Future Players" report to their offering. The report identifies and analyzes the key companies shaping and driving the Aortic Stent Grafts market. The report provides insight into the competitive Aortic Stent Grafts landscape, including new companies entering the market and pipeline products in development. Scope - Investigation of current and future market competition for Aortic Stent Grafts. - Competitor assessment including device approval analysis. - Coverage of key market players and company profiles including business description, financial overview and SWOT analysis. - Strategic assessment of the device sector through market impact analysis, future market scenario and company analysis. - Direct quotes from Key Opinion Leaders (KOL) as well as doctors using Aortic Stent Grafts in clinical practice. Key Topics Covered: 1 Tables & Figures 2 Introduction 3 Competitive Assessment 4 Pipeline Assessment 5 Current and Future Players 6 Appendix Companies Mentioned - Altura Medical - Aptus Endosystems - B. Braun - Bolton Medical - Braile Biom?dica - Cardiatis - Cook Medical - Endologix - Getinge Group - Gore Medical - Grikin Advanced Materials - Johnson & Johnson's Cordis Corporation - Jotec - LeMaitre Vascular - Lifetech Scientific - Lombard Medical - Medtronic - MicroPort Scientific Corporation - Nano Endoluminal - Terumo Corporation - TriVascular - Weike Medical Apparatus and Instrument - YTH Biological Material Scitech For more information visit http://www.researchandmarkets.com/research/pk...int_aortic
JNJ: 102.06 (+0.73), MDT: 77.93 (+0.80), EVAR: 4.09 (+0.01), LMAT: 8.38 (+0.08)
Global Intracranial Stents Market Outlook 2018
M2 - Tue Oct 21, 4:20AM CDT
Research and Markets (http://www.researchandmarkets.com/research/qlhkpr/global) has announced the addition of the "Global Intracranial Stents Market 2014-2018" report to their offering. The Global Intracranial Stents market to grow at a CAGR of 18.75% over the period 2013-2018 Intracranial stents are stainless steel mesh-like tubes with anatomic features to achieve a perfect combination of radial strength and flexibility. Intracranial stents are used in the treatments of cerebral aneurysms, intracranial aneurysms, and intracranial atherosclerosis that cause about eight percent of all ischemic strokes. One key trend in the market is the rise in demand for intracranial stenting procedures for aneurysm repair. The introduction of new intracranial devices with flow-diverters is feasible and effective with high complete occlusion rates, and intraoperative neurophysiological monitoring systems help as a tool for continuous functional monitoring of patients undergoing large-caliber vessel EC-IC bypass surgery. According to the report, the rise in the incidence of cerebral and other diseases, such as obesity and diabetes, is one of the major drivers of the market. Increasing incidence of aneurysms among people mainly aged above 45 years has led to an increase in the use of intracranial stenting procedures, thereby contributing to the growth of the market. Further, the report states that one of the major challenges in the market is the risk of complication, such as bleeding, chronic inflammation, in-stent restenosis, and thrombosis, during neurovascular/cerebrovascular procedures. Key Vendors - Covidien - DePuy Synthes - Medtonic - MicroPort Scientific - OBEX Medical - Stryker Other Prominent Vendors - Abbott Laboratories - Admedes Schuessler - BALT Extrusion - Cardiatis - Penumbra Key Topics Covered: - Executive Summary - List of Abbreviations - Scope of the Report - Market Research Methodology - Introduction - Market Landscape - Market Segmentation by Type of Stents - Geographical Segmentation - Buying Criteria - Late-stage Pipeline Products - Market Growth Drivers - Drivers and their Impact - Market Challenges - Impact of Drivers and Challenges - Market Trends - Trends and their Impact - Vendor Landscape - Key Vendor Analysis For more information visit http://www.researchandmarkets.com/research/qlhkpr/global
ABT: 47.15 (+0.15)
Aortic Stent Grafts - Global Analysis and Market Forecasts for the $1.2 Billion Industry
M2 - Mon Oct 20, 8:47AM CDT
Research and Markets (http://www.researchandmarkets.com/research/snm5b8/medipoint_aortic) has announced the addition of the "MediPoint: Aortic Stent Grafts - Global Analysis and Market Forecasts" report to their offering. The total aortic stent graft sales market in 2013 was estimated to be $1,224m across the 10MM By the end of the forecast, the stent graft sales market will grow to over $1,930m, with a Compound Annual Growth Rate (CAGR) of 6.7%. This report focuses on the aortic stent graft implant market for abdominal and thoracic aneurysms. The abdominal aortic market comprises about 80-90% of the market, with the niche market being the thoracic one. The thoracic aneurysm repair market is still a young market where there is a strong pipeline of products from both the large manufacturers and small emerging players. For most manufacturers, following the successful launch of an AAA product, the thoracic stent graft segment presents the opportunity with the most unmet needs for pursuit. The US market consists of the largest portion of the aortic stent graft market. The US and European Union (EU) combined formed close to 70% of the global share in 2013. In the remaining markets, Japan is the largest with China and Brazil to follow. India is by far, the smallest market. The EU is technologically the most advanced market, with the best availability of fenestrated and custom stent grafts on the market. The emerging markets see the most open surgical procedures, but stent use is restricted due to the cost of the products and procedures. As training programs for surgeons increase and product prices decrease, the emerging markets will present a strong opportunity for additional revenue for manufacturers. The overall CAGR across all 10 markets is 6.7%, with Japan and China representing the biggest growth opportunities. The growing concerns for multinational companies reside with the need to better target the fast-growing markets and the need to continue to be the leader in development to combat the threat of rising local manufacturers. The key drivers for the market in the forecast are: - The growing prevalence of aortic aneurysms along with the aging population across the globe with hypertension and obesity. - The growing technological advancement in minimally invasive procedures and the desire to eliminate the need for open surgical procedures for aneurysms. - The major underserved population for minimally invasive aneurysm treatment in the emerging markets that is driving the procedural numbers up. - The unmet need for better clinical outcomes and long-term studies to reduce the risk of endoleaks and other complications. Key Topics Covered: 1 Tables & Figures 2 Introduction 3 Industry Overview 4 Unmet Needs 5 Market Opportunity Analysis 6 Market Drivers, Barriers, and Substitutes 7 Competitive Assessment 8 Pipeline Assessment 9 Clinical Trials to Watch 10 Current and Future Players 11 Market Outlook 12 Appendix Companies Mentioned - Cook Medical - Endologix - Gore Medical - Medtronic - Terumo Corporation - Altura Medical - Aptus Endosystems - Bolton Medical - Braile Biom?dica - B. Braun - Cardiatis - LeMaitre Vascular - Lifetech Scientific - Getinge Group - Grikin Advanced Materials - Johnson & Johnson's Cordis Corporation - Jotec - Lombard Medical - MicroPort Scientific Corporation - Nano Endoluminal - TriVascular - Weike Medical Apparatus and Instrument - YTH Biological Material Scitech For more information visit http://www.researchandmarkets.com/research/sn...int_aortic
JNJ: 102.06 (+0.73), MDT: 77.93 (+0.80), EVAR: 4.09 (+0.01), LMAT: 8.38 (+0.08)
China Orthopedic Instrument Industry Report, 2014-2017
PR Newswire - Thu Oct 02, 2:44PM CDT
Benefiting from accelerated aging population and rising proportion of reimbursement for medical expenses, the Chinese orthopedic instrument market demand has been effectively released, with its scale presenting a CAGR of 19.2% during 2009-2013. Trauma products, spine products and joint products are three product segments of orthopedic instruments in China, of which trauma products holding the bulk with 36.9% market share in 2013.
MDT: 77.93 (+0.80), SYK: 93.74 (+0.67)
China Orthopedic Instrument Industry 2014- Global Industry Size, Share, Trend, Growth and Forecast 2017
PRWeb - Fri Aug 22, 6:16AM CDT
Being optimistic about the bright future of the Chinese orthopedic instrument industry, some foreign and domestic companies are speeding up their layout in orthopedic instrument market though mergers and acquisitions. In 2012, Medtronic, Inc. acquired the most competitive orthopedic device maker in China-- China Kanghui Holdings for USD 816 million; In Jan. 2013, Stryker Corporation bought China's largest trauma product makers-- Trauson Holdings Company Limited for HKD5.9 billion; In Sep. 2011, MicroPort Scientific Corporation entered orthopedic instrument market by purchasing Suzhou Best at transaction value of RMB 110 million, and acquired Wright's OrthoRecon business at USD 290 million in Jan. 2014.
MDT: 77.93 (+0.80), SYK: 93.74 (+0.67)
Intracranial Stents - 2015-2020 Global Strategic Business Report: Medical Tourism Buoys Demand for Stenting Procedures in Emerging Nations
M2 - Tue Mar 31, 6:17AM CDT
Research and Markets (http://www.researchandmarkets.com/research/24lv7t/intracranial) has announced the addition of the "Intracranial Stents - Global Strategic Business Report" report to their offering. This report analyzes the worldwide markets for Intracranial Stents in US$ Thousands. The report provides separate comprehensive analytics for the US, Europe, and Rest of World. Annual estimates and forecasts are provided for the period 2013 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 14 companies including many key and niche players such as: - Admedes Schuessler GmbH (Germany) - BALT Extrusion (France) - Cardiatis SA (Belgium) - Codman & Shurtleff, Inc. (US) - Covidien PLC (Ireland) - ITGI Medical Ltd. (Israel) - MicroPort Scientific Corporation (China) - OBEX Medical (New Zealand) - Stryker Corp. (US) Key Topics Covered: 1. INDUSTRY OVERVIEW 2. INTRACRANIAL STENTS AVAILABLE IN THE MARKET 3. MARKET DRIVERS & TRENDS 4. PRODUCT OVERVIEW 5. NEUROVASCULAR DISEASES - AN OVERVIEW 6. MAJOR NEUROVASCULAR INDICATIONS REQUIRING STENTING PROCEDURES 7. PRODUCT INTRODUCTIONS & APPROVALS 8. RECENT INDUSTRY ACTIVITY 9. FOCUS ON SELECT PLAYERS 10. GLOBAL MARKET PERSPECTIVE Total Companies Profiled: 14 (including Divisions/Subsidiaries - 17) - The United States (6) - Europe (6) - - France (1) - - Germany (3) - - Rest of Europe (2) - Asia-Pacific (Excluding Japan) (4) - Middle East (1) For more information visit http://www.researchandmarkets.com/research/24...tracranial
SYK: 93.74 (+0.67)
MediPoint: Coronary Stents - South America Analysis and Market Forecasts to 2020
M2 - Wed Mar 25, 6:07AM CDT
Research and Markets (http://www.researchandmarkets.com/research/lz276h/medipoint) has announced the addition of the "MediPoint: Coronary Stents - SA Analysis and Market Forecasts" report to their offering. The global coronary stents market is a dynamic, double-digit market that is saturated with numerous players developing innovative technologies. Rapid advances in the field of interventional cardiology along with the development of minimally invasive techniques have greatly expanded the potential of therapeutic applications. Coronary stents including bare metal, drug-eluting, covered and bioabsorbable stents can be used to treat coronary artery disease, and optimize outcomes. Minimally-invasive techniques such as stenting have been widely adopted in Brazil. The coronary stents market will be driven by the rising prevalence of CAD, the growing aging population, and the potential cost savings associated with DES technologies. Scope - An overview of Coronary Stents, which includes epidemiology, etiology, symptoms, diagnosis, pathology and treatment guidelines. - Annualized the SA Coronary Stents market revenue and future forecasts from 2011 to 2013, forecast for 7 years to 2020. - Investigation of current and future market competition for Coronary Stents. - Insightful review of the key industry drivers, restraints and challenges as well as predicted impact of key events. - Competitor assessment including device approval analysis and device sales forecasts. - Marketed and pipeline product profiles covering efficiency, safety, clinical study details, device approvals, product positioning and device sales forecast. - Analysis of unmet needs within the market and opportunities for future players. - Technology trends evaluation to assess strength of pipeline. - An overview of all devices in development including clinical study details, design and material selection considerations, efficacy reports, and device approval timelines. - Company profiles including business description, financial overview and SWOT analysis. - Coverage of key market players. - Strategic assessment of the Coronary Stents sector through market impact analysis, future market scenario and company analysis. - Direct quotes from Key Opinion Leaders (KOL) as well as doctors Key Topics Covered: 1 Tables & Figures 2 Introduction 3 Industry Overview 4 Unmet Needs 5 Market Opportunity Analysis 6 Market Drivers, Barriers, and Substitutes 7 Competitive Assessment 8 Pipeline Products 9 Clinical Trial Analysis 10 Current and Future Players 11 Market Outlook 12 Appendix Companies Mentioned - Abbott Vascular - Boston Scientific Corporation - Medtronic - Alvimedica - Amaranth Medical - amg International - Arterial Remodeling Technologies - B. Braun - Balton - Biosensors International - Biotronik - Blue Medical - Cardionovum - C.R. Bard - Elixir Medical Corporation - eucatech AG - Hexacath - JW Medical Systems - Kyoto Medical Planning - Lepu Medical Technology - MicroPort Scientific Corporation - Minvasys - MIV Therapeutics - Opto Circuits - OrbusNeich Medical - Relisys Medical Devices - Sahajanand Medical Technologies - Terumo Corporation - Translumina - Vascular Concepts For more information visit http://www.researchandmarkets.com/research/lz276h/medipoint
BSX: 18.10 (unch), MDT: 77.93 (+0.80)
MediPoint: Coronary Stents - APAC Analysis and Market Forecasts to 2020
M2 - Wed Mar 25, 5:47AM CDT
Research and Markets (http://www.researchandmarkets.com/research/qvwjmw/medipoint) has announced the addition of the "MediPoint: Coronary Stents - APAC Analysis and Market Forecasts" report to their offering. The APAC countries have diverse populations, ethnicities, and clinical practices. Many of the developed economies in these regions have a growing aging population, given the improvements made in healthcare (Cheng, 2010). Japan is one of the largest markets for cardiovascular devices in the world due to its advanced healthcare system and high pricing. In 2013, Among the emerging markets, which include Brazil, China, and India, China has the largest share in the coronary stents market for treating CAD. Scope - An overview of Coronary Stents, which includes epidemiology, etiology, symptoms, diagnosis, pathology and treatment guidelines. - Annualized the APAC Coronary Stents market revenue and future forecasts from 2011 to 2013, forecast for 7 years to 2020. - Investigation of current and future market competition for Coronary Stents. - Insightful review of the key industry drivers, restraints and challenges as well as predicted impact of key events. - Competitor assessment including device approval analysis and device sales forecasts. - Marketed and pipeline product profiles covering efficiency, safety, clinical study details, device approvals, product positioning and device sales forecast. - Analysis of unmet needs within the market and opportunities for future players. - Technology trends evaluation to assess strength of pipeline. - An overview of all devices in development including clinical study details, design and material selection considerations, efficacy reports, and device approval timelines. - Company profiles including business description, financial overview and SWOT analysis. - Coverage of key market players. - Strategic assessment of the Coronary Stents sector through market impact analysis, future market scenario and company analysis. - Direct quotes from Key Opinion Leaders (KOL) as well as doctors Key Topics Covered: 1 Tables & Figures 2 Introduction 3 Industry Overview 4 Unmet Needs 5 Market Opportunity Analysis 6 Market Drivers, Barriers, and Substitutes 7 Competitive Assessment 8 Pipeline Products 9 Clinical Trial Analysis 10 Current and Future Players 11 Market Outlook 12 Appendix Companies Mentioned - Abbott Vascular - Boston Scientific Corporation - Medtronic - Alvimedica - Amaranth Medical - amg International - Arterial Remodeling Technologies - B. Braun - Balton - Biosensors International - Biotronik - Blue Medical - Cardionovum - C.R. Bard - Elixir Medical Corporation - eucatech AG - Hexacath - IRAMED - JW Medical Systems - Kyoto Medical Planning - Lepu Medical Technology - MicroPort Scientific Corporation - Minvasys - MIV Therapeutics - Opto Circuits - OrbusNeich Medical - Relisys Medical Devices - REVA Medical - Sahajanand Medical Technologies - STENTYS For more information visit http://www.researchandmarkets.com/research/qvwjmw/medipoint
BSX: 18.10 (unch), MDT: 77.93 (+0.80)
Global Coronary Stents Market Outlook Report 2015 - Analysis and Forecasts 2007-2020
M2 - Thu Mar 19, 6:39AM CDT
Research and Markets (http://www.researchandmarkets.com/research/jfw4v9/global_coronary) has announced the addition of the "Global Coronary Stents Market Outlook, 2007 - 2020" report to their offering. The global coronary stent market is expected grow, despite the current downward trend in the US, the largest market, and declining selling prices globally. The market study takes into account various global clinical studies and pipeline products and it suggests that the coronary stent pipeline is clustered with new generation Drug Eluting Stent (DES), bioactive stents, bioabsorbable technology and stents for the niche segments such as complex and bifurcated vessels. Altering the trend, small to medium size companies from the developing economies are ambitiously conducting clinical studies to win the approvals and expand the use of devices for new indications. The stent market globally and in the developed nations is largely controlled by three playersAbbott Laboratories, Boston Scientific, and Medtronic. While in developing economies, small and medium players from Asia and Europe have a considerable share in terms of volume. This comprehensive, 465 page global strategic business report is authored by team of sector analysts who used rigorous primary and secondary research, robust analytical model to provide strategic insight and to forecast in for all major stent types BMS, DES, Bioabsorbable stents in leading 23 geographies. Key Topics Covered: 1. Charts & Tables 2. Executive Summary 3. Market at a Glance 4. Introduction to Stents 5. Coronary Stents 6. Types of Stents 7. Approvals 8. Competitive Landscape 9. Clinical Studies 10. Coronary Stents - Market Drivers and Restrains 11. Overview: Market trends 12. Approvals Driving the Growth 13. Market Data 14. Company Profiles 15. Recent Events 16. Appendix Companies Mentioned - Abbott Vascular - Alvimedica Medical Technologies - Arterial Remodeling Technologies - Boston Scientific Corporation - Biosensors International - Biotronik SE & Co.kG - CID S.r.l. - Clearstream Technologies Ltd. - Disa Vascular (Pty) Ltd. - Elixir Medical Corporation - Endocor Gmbh - Essen Technology (Beijing) Co., Ltd - Hexacath - Iberhospitex S.A - InspireMD, Inc. - Japan Stent Technology Co., Ltd. - Kyoto Medical - Lepu Medical Technology Co., Ltd. - Medinol - Medtronic, Inc. - Meril Life Sciences Pvt. Ltd. - Micell Technologies, Inc. - MicroPort Scientific Corporation - Minvasys - OrbusNeich - Relisys Medical Devices Limited - Reva Medical, Inc. - Sahajanand Medical Technologies - Stentys - Vascular Concepts For more information visit http://www.researchandmarkets.com/research/jf...l_coronary
BSX: 18.10 (unch), MDT: 77.93 (+0.80), NSPR: 0.32 (unch)
MediPoint: Coronary Stents - US Analysis and Market Forecasts
M2 - Thu Dec 04, 5:22AM CST
Research and Markets (http://www.researchandmarkets.com/research/xrr3sw/medipoint) has announced the addition of the "MediPoint: Coronary Stents - US Analysis and Market Forecasts" report to their offering. The global coronary stents market is a dynamic, double-digit market that is saturated with numerous players developing innovative technologies. Rapid advances in the field of interventional cardiology along with the development of minimally invasive techniques have greatly expanded the potential of therapeutic applications. Coronary stents including bare metal, drug-eluting, covered and bioabsorbable stents can be used to treat coronary artery disease, and optimize outcomes. Each year, millions of individuals are affected by CAD worldwide. Given the high burden of the disease, it is important to develop innovative technologies that can improve outcomes and disease management. Stenting for coronary applications has been widely adopted in clinical practice worldwide, and can be used in a wide range of indications. By 2020, the coronary stents market for BMS and DES is estimated to be over $5.61 billion. Key Topics Covered: 1 List of Tables 2 Introduction 3 Industry Overview 4 Unmet Needs 5 Market Opportunity Analysis 6 Market Drivers, Barriers, and Substitutes 7 Competitive Assessment 8 Pipeline Products 9 Clinical Trial Analysis 10 Current and Future Players 11 Market Outlook 12 Appendix Companies Mentioned: - Abbott Vascular - Alvimedica - Amaranth Medical - Arterial Remodeling Technologies - B. Braun - Balton - Biosensors International - Biotronik - Blue Medical - Boston Scientific Corporation - C.R. Bard - Cardionovum - Elixir Medical Corporation - Hexacath - IRAMED - JW Medical Systems - Kyoto Medical Planning - Lepu Medical Technology - MIV Therapeutics - Medtronic - MicroPort Scientific Corporation - Minvasys - Opto Circuits - OrbusNeich Medical - REVA Medical - Relisys Medical Devices - STENTYS - Sahajanand Medical Technologies - Terumo Corporation - Translumina - Vascular Concepts - amg International - eucatech AG For more information visit http://www.researchandmarkets.com/research/xrr3sw/medipoint
BSX: 18.10 (unch), MDT: 77.93 (+0.80)
MediPoint: Coronary Stents - Current and Future Players
M2 - Thu Dec 04, 4:11AM CST
Research and Markets (http://www.researchandmarkets.com/research/vrst8n/medipoint) has announced the addition of the "MediPoint: Coronary Stents - Current and Future Players" report to their offering. The global coronary stents market is a dynamic, double-digit market that is saturated with numerous players developing innovative technologies. Rapid advances in the field of interventional cardiology along with the development of minimally invasive techniques have greatly expanded the potential of therapeutic applications. Coronary stents including bare metal, drug-eluting, covered and bioabsorbable stents can be used to treat coronary artery disease, and optimize outcomes. The coronary stents market is a vast and dynamic market that is saturated with numerous players worldwide. The competitive landscape consists of large, mid-size, and small companies that have developed different types of coronary stents to target various coronary indications, such as de novo lesions, AMI, STEMI, SVD, and bifurcation lesions. The coronary stents market is largely dominated by a few key players, including Abbott Vascular, Boston Scientific, and Medtronic, followed by Biosensors International and Terumo Corporation. Scope - Investigation of current and future market competition for Coronary Stents. - Competitor assessment including device approval analysis. - Coverage of key market players and company profiles including business description, financial overview and SWOT analysis. - Strategic assessment of the device sector through market impact analysis, future market scenario and company analysis. - Direct quotes from Key Opinion Leaders (KOL) as well as doctors using Coronary Stents in clinical practice. Key Topics Covered: 1 List of Tables 2 Introduction 3 Competitive Assessment 4 Pipeline Products 5 Current and Future Players 6 Appendix Companies Mentioned: - Abbott Vascular - Alvimedica - Amaranth Medical - Arterial Remodeling Technologies - B. Braun - Balton - Biosensors International - Biotronik - Blue Medical - Boston Scientific Corporation - C.R. Bard - Cardionovum - Elixir Medical Corporation - Hexacath - IRAMED - JW Medical Systems - Kyoto Medical Planning - Lepu Medical Technology - MIV Therapeutics - Medtronic - MicroPort Scientific Corporation - Minvasys - Opto Circuits - REVA Medical - Relisys Medical Devices - STENTYS - Sahajanand Medical Technologies - Terumo Corporation - Translumina - Vascular Concepts - amg International - eucatech AG For more information visit http://www.researchandmarkets.com/research/vrst8n/medipoint
BSX: 18.10 (unch), MDT: 77.93 (+0.80)
MediPoint: Aortic Stent Grafts - South America Analysis and Market Forecasts
M2 - Thu Dec 04, 4:01AM CST
Research and Markets (http://www.researchandmarkets.com/research/8b8djj/medipoint_aortic) has announced the addition of the "MediPoint: Aortic Stent Grafts - South America Analysis and Market Forecasts" report to their offering. Aortic stent grafts are most commonly used to reinforce a weak spot in an artery, which is known as an aneurysm. The stent grafts are designed to seal tightly with the patient's native artery above and below the aneurysm, and are used to treat abdominal aortic aneurysms as well as thoracic aortic aneurysms. Reasons to buy - Understand the trends shaping and driving the South America Aortic Stent Grafts market. - Realize device preferences of physicians who have performed the tests already. - Access market sizing, forecasts and quantified growth opportunities in South America Aortic Stent Grafts market through 2018. - Quantify candidate patient populations to better design product pricing & launch plans. - Drive revenues, formulate effective sales and marketing strategies and gain in-depth understanding of the competitive landscape. - Perform benchmarking analysis of growth opportunities against currently marketed products. - Assess competitiveness of products in market by understanding the strengths and weaknesses of current competition. - Take a comprehensive look at the market's device pipeline and identify promising, paradigm-shifting products. - Create an effective counter-strategy to gain a competitive advantage against those currently in the market. Key Topics Covered: 1 List of Tables 2 Introduction 3 Industry Overview 4 Unmet Needs 5 Market Opportunity Analysis 6 Market Drivers, Barriers, and Substitutes 7 Competitive Assessment 8 Pipeline Assessment 9 Clinical Trials to Watch 10 Current and Future Players 11 Market Outlook 12 Appendix Companies Mentioned: - Altura Medical - Aptus Endosystems - B. Braun - Bolton Medical - Braile Biomedica - Cardiatis - Cook Medical - Endologix - Getinge Group - Gore Medical - Grikin Advanced Materials - Johnson & Johnson's Cordis Corporation - Jotec - LeMaitre Vascular - Lifetech Scientific - Lombard Medical - Medtronic - MicroPort Scientific Corporation - Nano Endoluminal - Terumo Corporation - TriVascular - Weike Medical Apparatus and Instrument - YTH Biological Material Scitech For more information visit http://www.researchandmarkets.com/research/8b...int_aortic
JNJ: 102.06 (+0.73), MDT: 77.93 (+0.80), EVAR: 4.09 (+0.01), LMAT: 8.38 (+0.08)
MediPoint: Aortic Stent Grafts - APAC Analysis and Market Forecasts
M2 - Thu Dec 04, 3:55AM CST
Research and Markets (http://www.researchandmarkets.com/research/fxpfd4/medipoint_aortic) has announced the addition of the "MediPoint: Aortic Stent Grafts - APAC Analysis and Market Forecasts" report to their offering. Aortic stent grafts are most commonly used to reinforce a weak spot in an artery, which is known as an aneurysm. The stent grafts are designed to seal tightly with the patient's native artery above and below the aneurysm, and are used to treat abdominal aortic aneurysms as well as thoracic aortic aneurysms. Reasons to buy - Understand the trends shaping and driving the APAC Aortic Stent Grafts market. - Realize device preferences of physicians who have performed the tests already. - Access market sizing, forecasts and quantified growth opportunities in the APAC Aortic Stent Grafts market through 2018. - Quantify candidate patient populations to better design product pricing & launch plans. - Drive revenues, formulate effective sales and marketing strategies and gain in-depth understanding of the competitive landscape. - Perform benchmarking analysis of growth opportunities against currently marketed products. - Assess competitiveness of products in market by understanding the strengths and weaknesses of current competition. - Take a comprehensive look at the market's device pipeline and identify promising, paradigm-shifting products. - Create an effective counter-strategy to gain a competitive advantage against those currently in the market. - Organize your sales and marketing efforts by identifying the market categories and segments that present the best opportunities for growth. Key Topics Covered: 1 List of Tables 2 Introduction 3 Industry Overview 4 Unmet Needs 5 Market Opportunity Analysis 6 Market Drivers, Barriers, and Substitutes 7 Competitive Assessment 8 Pipeline Assessment 9 Clinical Trials to Watch 10 Current and Future Players 11 Market Outlook 12 Appendix Companies Mentioned: - Altura - Aptus - B. Braun - Bolton - Braile Biomedica - Cardiatis - Cook - Endologix - Getinge - Gore - Grikin Advanced Materials - Johnson & Johnson's - Jotec - LeMaitre Vascular - Lifetech - Lombard - Medtronic - MicroPort Scientific - Nano Endoluminal - Terumo - TriVascular - Weike Medical Apparatus and Instrument - YTH Biological Material For more information visit http://www.researchandmarkets.com/research/fx...int_aortic
JNJ: 102.06 (+0.73), MDT: 77.93 (+0.80), LMAT: 8.38 (+0.08)
MediPoint: Aortic Stent Grafts - US Analysis and Market Forecasts 2013-2020
M2 - Mon Nov 24, 8:35AM CST
Research and Markets (http://www.researchandmarkets.com/research/lvjkp8/medipoint_aortic) has announced the addition of the "MediPoint: Aortic Stent Grafts - US Analysis and Market Forecasts" report to their offering. Aortic stent grafts are most commonly used to reinforce a weak spot in an artery, which is known as an aneurysm. The stent grafts are designed to seal tightly with the patient's native artery above and below the aneurysm, and are used to treat abdominal aortic aneurysms as well as thoracic aortic aneurysms. Aortic aneurysms, as opposed to aneurysms found elsewhere in the body, are potentially very serious, as a burst aorta results in massive internal bleeding that can be fatal unless treated rapidly by an experienced emergency medical team. The US market is the largest market for aortic stent grafts, accounting for more than 40% of the global market. The US market is very similar to that of the global market with regard to the trends in market share. Gore Medical remains the leader in the US for both the EVAR and TEVAR markets. These three companies also offer market leading products for treating AAA and TAA, ensuring long-term, effective solutions to patients. Scope - An overview of Aortic Stent Grafts, which includes epidemiology, etiology, symptoms, diagnosis, pathology and treatment guidelines. - Annualized the US Aortic Stent Grafts market revenue and future forecasts from 2011 to 2013, forecast for 7 years to 2020. - Investigation of current and future market competition for Aortic Stent Grafts. - Insightful review of the key industry drivers, restraints and challenges as well as predicted impact of key events. - Competitor assessment including device approval analysis and device sales forecasts. - Marketed and pipeline product profiles covering efficiency, safety, clinical study details, device approvals, product positioning and device sales forecast. - Analysis of unmet needs within the market and opportunities for future players. - Technology trends evaluation to assess strength of pipeline. - An overview of all devices in development including clinical study details, design and material selection considerations, efficacy reports, and device approval timelines. - Company profiles including business description, financial overview and SWOT analysis. - Coverage of key market players. - Strategic assessment of the Aortic Stent Grafts sector through market impact analysis, future market scenario and company analysis. - Direct quotes from Key Opinion Leaders (KOL) as well as doctors Key Topics Covered: 1 Tables & Figures 2 Introduction 3 Industry Overview 4 Unmet Needs 5 Market Opportunity Analysis 6 Market Drivers, Barriers, and Substitutes 7 Competitive Assessment 8 Pipeline Assessment 9 Clinical Trials to Watch 10 Current and Future Players 11 Market Outlook 12 Appendix Companies Mentioned - Altura Medical - Aptus Endosystems - B. Braun - Bolton Medical - Braile Biom?dica - Cardiatis - Cook Medical - Endologix - Getinge Group - Gore Medical - Grikin Advanced Materials - Johnson & Johnson's Cordis Corporation - Jotec - LeMaitre Vascular - Lifetech Scientific - Lombard Medical - Medtronic - MicroPort Scientific Corporation - Nano Endoluminal - Terumo Corporation - TriVascular - Weike Medical Apparatus and Instrument - YTH Biological Material Scitech For more information visit http://www.researchandmarkets.com/research/lv...int_aortic
JNJ: 102.06 (+0.73), MDT: 77.93 (+0.80), EVAR: 4.09 (+0.01), LMAT: 8.38 (+0.08)
MediPoint: Coronary Stents - Global Analysis and Market Forecasts to 2020 for the $5.6 Billion Industry
M2 - Fri Nov 21, 9:31AM CST
Research and Markets (http://www.researchandmarkets.com/research/dx86qv/medipoint) has announced the addition of the "MediPoint: Coronary Stents - Global Analysis and Market Forecasts" report to their offering. Coronary Stent Sales by Region Coronary stents can be used for a wide range of indications in coronary artery disease (CAD), including de novo lesions, small-vessel disease (SVD), bifurcation lesions, and tortuous and narrow lesions. Coronary stents can improve the clinical outcomes for all of these indications as well as quality of life for patients suffering from this debilitating disease. In 2013, sales of DES and BMS in the 10MM were $4.89 billion. The authors estimates the 2014 sales of DES and BMS in the 10MM to be $4.99 billion. By 2020, sales of coronary stents, including bare metal and drug-eluting stents, will grow to $5.62 billion, at a Compound Annual Growth Rate (CAGR) of 2.0%. To date, BAS have not received regulatory approval and been launched in the US, Japanese, and Chinese markets, but are expected to enter these markets in the near future. Of the 10MM covered in the report, the US currently has and will continue to have the largest share in the coronary stents market. Together, the US, the 5EU countries, and Japan will account for 64% of the coronary stents market for BMS and DES in 2020. Collectively, the 5EU countries are forecast to have only 10% market share in the future. Among the emerging markets, China has captured significant market share, which is expected to increase in the future. The emerging markets, including Brazil, China, and India, are expected to demonstrate the greatest growth in the market over the forecast period and will serve as an outlet of expansion for stent manufacturers to increase their global presence. The key drivers for the coronary stents market during the forecast period are: - The rising prevalence of CAD in the major markets covered in this report - The need for effective therapies that reduce the risk of complications, such as restenosis (re-narrowing of the coronary artery), chronic inflammation, and thrombosis, and the need for target lesion revascularization (TLR) associated with bare metal and drug-eluting stenting - The cost savings for healthcare payers resulting from the reduced need for repeat revascularization procedures and prolonged dual antiplatelet therapy - Reducing the need for stent-in-stent procedures and improving the technical feasibility of future interventions - Innovations in stent technology with regard to the platform, material, and coating - The increase in patients' disposable income and government insurance coverage in the emerging markets, such as China and India - The approval and launch of BAS, such as the Absorb BVS, in the US, Japan, and China Key Topics Covered: 1 Tables & Figures 2 Introduction 3 Industry Overview 4 Unmet Needs 5 Market Opportunity Analysis 6 Market Drivers, Barriers, and Substitutes 7 Competitive Assessment 8 Pipeline Products 9 Clinical Trial Analysis 10 Current and Future Players 11 Market Outlook 12 Appendix Companies Mentioned - Abbott Vascular - Alvimedica - Amaranth Medical - Arterial Remodeling Technologies - B. Braun - Balton - Biosensors International - Biotronik - Blue Medical - Boston Scientific Corporation - C.R. Bard - Cardionovum - Elixir Medical Corporation - Hexacath - IRAMED - JW Medical Systems - Kyoto Medical Planning - Lepu Medical Technology - MIV Therapeutics - Medtronic - MicroPort Scientific Corporation - Minvasys - Opto Circuits - OrbusNeich Medical - REVA Medical - Relisys Medical Devices - STENTYS - Sahajanand Medical Technologies - Terumo Corporation - Translumina For more information visit http://www.researchandmarkets.com/research/dx86qv/medipoint
BSX: 18.10 (unch), MDT: 77.93 (+0.80)
MediPoint: Aortic Stent Grafts - Current and Future Players
M2 - Tue Nov 18, 8:37AM CST
Research and Markets (http://www.researchandmarkets.com/research/pk7mdq/medipoint_aortic) has announced the addition of the "MediPoint: Aortic Stent Grafts - Current and Future Players" report to their offering. The report identifies and analyzes the key companies shaping and driving the Aortic Stent Grafts market. The report provides insight into the competitive Aortic Stent Grafts landscape, including new companies entering the market and pipeline products in development. Scope - Investigation of current and future market competition for Aortic Stent Grafts. - Competitor assessment including device approval analysis. - Coverage of key market players and company profiles including business description, financial overview and SWOT analysis. - Strategic assessment of the device sector through market impact analysis, future market scenario and company analysis. - Direct quotes from Key Opinion Leaders (KOL) as well as doctors using Aortic Stent Grafts in clinical practice. Key Topics Covered: 1 Tables & Figures 2 Introduction 3 Competitive Assessment 4 Pipeline Assessment 5 Current and Future Players 6 Appendix Companies Mentioned - Altura Medical - Aptus Endosystems - B. Braun - Bolton Medical - Braile Biom?dica - Cardiatis - Cook Medical - Endologix - Getinge Group - Gore Medical - Grikin Advanced Materials - Johnson & Johnson's Cordis Corporation - Jotec - LeMaitre Vascular - Lifetech Scientific - Lombard Medical - Medtronic - MicroPort Scientific Corporation - Nano Endoluminal - Terumo Corporation - TriVascular - Weike Medical Apparatus and Instrument - YTH Biological Material Scitech For more information visit http://www.researchandmarkets.com/research/pk...int_aortic
JNJ: 102.06 (+0.73), MDT: 77.93 (+0.80), EVAR: 4.09 (+0.01), LMAT: 8.38 (+0.08)
Global Intracranial Stents Market Outlook 2018
M2 - Tue Oct 21, 4:20AM CDT
Research and Markets (http://www.researchandmarkets.com/research/qlhkpr/global) has announced the addition of the "Global Intracranial Stents Market 2014-2018" report to their offering. The Global Intracranial Stents market to grow at a CAGR of 18.75% over the period 2013-2018 Intracranial stents are stainless steel mesh-like tubes with anatomic features to achieve a perfect combination of radial strength and flexibility. Intracranial stents are used in the treatments of cerebral aneurysms, intracranial aneurysms, and intracranial atherosclerosis that cause about eight percent of all ischemic strokes. One key trend in the market is the rise in demand for intracranial stenting procedures for aneurysm repair. The introduction of new intracranial devices with flow-diverters is feasible and effective with high complete occlusion rates, and intraoperative neurophysiological monitoring systems help as a tool for continuous functional monitoring of patients undergoing large-caliber vessel EC-IC bypass surgery. According to the report, the rise in the incidence of cerebral and other diseases, such as obesity and diabetes, is one of the major drivers of the market. Increasing incidence of aneurysms among people mainly aged above 45 years has led to an increase in the use of intracranial stenting procedures, thereby contributing to the growth of the market. Further, the report states that one of the major challenges in the market is the risk of complication, such as bleeding, chronic inflammation, in-stent restenosis, and thrombosis, during neurovascular/cerebrovascular procedures. Key Vendors - Covidien - DePuy Synthes - Medtonic - MicroPort Scientific - OBEX Medical - Stryker Other Prominent Vendors - Abbott Laboratories - Admedes Schuessler - BALT Extrusion - Cardiatis - Penumbra Key Topics Covered: - Executive Summary - List of Abbreviations - Scope of the Report - Market Research Methodology - Introduction - Market Landscape - Market Segmentation by Type of Stents - Geographical Segmentation - Buying Criteria - Late-stage Pipeline Products - Market Growth Drivers - Drivers and their Impact - Market Challenges - Impact of Drivers and Challenges - Market Trends - Trends and their Impact - Vendor Landscape - Key Vendor Analysis For more information visit http://www.researchandmarkets.com/research/qlhkpr/global
ABT: 47.15 (+0.15)
Aortic Stent Grafts - Global Analysis and Market Forecasts for the $1.2 Billion Industry
M2 - Mon Oct 20, 8:47AM CDT
Research and Markets (http://www.researchandmarkets.com/research/snm5b8/medipoint_aortic) has announced the addition of the "MediPoint: Aortic Stent Grafts - Global Analysis and Market Forecasts" report to their offering. The total aortic stent graft sales market in 2013 was estimated to be $1,224m across the 10MM By the end of the forecast, the stent graft sales market will grow to over $1,930m, with a Compound Annual Growth Rate (CAGR) of 6.7%. This report focuses on the aortic stent graft implant market for abdominal and thoracic aneurysms. The abdominal aortic market comprises about 80-90% of the market, with the niche market being the thoracic one. The thoracic aneurysm repair market is still a young market where there is a strong pipeline of products from both the large manufacturers and small emerging players. For most manufacturers, following the successful launch of an AAA product, the thoracic stent graft segment presents the opportunity with the most unmet needs for pursuit. The US market consists of the largest portion of the aortic stent graft market. The US and European Union (EU) combined formed close to 70% of the global share in 2013. In the remaining markets, Japan is the largest with China and Brazil to follow. India is by far, the smallest market. The EU is technologically the most advanced market, with the best availability of fenestrated and custom stent grafts on the market. The emerging markets see the most open surgical procedures, but stent use is restricted due to the cost of the products and procedures. As training programs for surgeons increase and product prices decrease, the emerging markets will present a strong opportunity for additional revenue for manufacturers. The overall CAGR across all 10 markets is 6.7%, with Japan and China representing the biggest growth opportunities. The growing concerns for multinational companies reside with the need to better target the fast-growing markets and the need to continue to be the leader in development to combat the threat of rising local manufacturers. The key drivers for the market in the forecast are: - The growing prevalence of aortic aneurysms along with the aging population across the globe with hypertension and obesity. - The growing technological advancement in minimally invasive procedures and the desire to eliminate the need for open surgical procedures for aneurysms. - The major underserved population for minimally invasive aneurysm treatment in the emerging markets that is driving the procedural numbers up. - The unmet need for better clinical outcomes and long-term studies to reduce the risk of endoleaks and other complications. Key Topics Covered: 1 Tables & Figures 2 Introduction 3 Industry Overview 4 Unmet Needs 5 Market Opportunity Analysis 6 Market Drivers, Barriers, and Substitutes 7 Competitive Assessment 8 Pipeline Assessment 9 Clinical Trials to Watch 10 Current and Future Players 11 Market Outlook 12 Appendix Companies Mentioned - Cook Medical - Endologix - Gore Medical - Medtronic - Terumo Corporation - Altura Medical - Aptus Endosystems - Bolton Medical - Braile Biom?dica - B. Braun - Cardiatis - LeMaitre Vascular - Lifetech Scientific - Getinge Group - Grikin Advanced Materials - Johnson & Johnson's Cordis Corporation - Jotec - Lombard Medical - MicroPort Scientific Corporation - Nano Endoluminal - TriVascular - Weike Medical Apparatus and Instrument - YTH Biological Material Scitech For more information visit http://www.researchandmarkets.com/research/sn...int_aortic
JNJ: 102.06 (+0.73), MDT: 77.93 (+0.80), EVAR: 4.09 (+0.01), LMAT: 8.38 (+0.08)
China Orthopedic Instrument Industry Report, 2014-2017
PR Newswire - Thu Oct 02, 2:44PM CDT
Benefiting from accelerated aging population and rising proportion of reimbursement for medical expenses, the Chinese orthopedic instrument market demand has been effectively released, with its scale presenting a CAGR of 19.2% during 2009-2013. Trauma products, spine products and joint products are three product segments of orthopedic instruments in China, of which trauma products holding the bulk with 36.9% market share in 2013.
MDT: 77.93 (+0.80), SYK: 93.74 (+0.67)
China Orthopedic Instrument Industry 2014- Global Industry Size, Share, Trend, Growth and Forecast 2017
PRWeb - Fri Aug 22, 6:16AM CDT
Being optimistic about the bright future of the Chinese orthopedic instrument industry, some foreign and domestic companies are speeding up their layout in orthopedic instrument market though mergers and acquisitions. In 2012, Medtronic, Inc. acquired the most competitive orthopedic device maker in China-- China Kanghui Holdings for USD 816 million; In Jan. 2013, Stryker Corporation bought China's largest trauma product makers-- Trauson Holdings Company Limited for HKD5.9 billion; In Sep. 2011, MicroPort Scientific Corporation entered orthopedic instrument market by purchasing Suzhou Best at transaction value of RMB 110 million, and acquired Wright's OrthoRecon business at USD 290 million in Jan. 2014.
MDT: 77.93 (+0.80), SYK: 93.74 (+0.67)
